HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 95/4/2108    most recent 01118.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by André, V. M. Articles by Levine, M. S. Search for Related Content PubMed PubMed Citation Articles by André, V. M. Articles by Levine, M. S.

Altered Cortical Glutamate Receptor Function in the R6/2 Model of Huntington's Disease

Mental Retardation Research Center, David Geffen School of Medicine, University of California, Los Angeles, California

Submitted 24 October 2005; accepted in final form 23 December 2005

Alterations in pyramidal neurons from the sensorimotor cortex may be responsible for some of the cognitive and motor symptoms of Huntington's disease (HD). The present experiments used R6/2 transgenic mice that express exon 1 of the human HD gene with an expanded number of CAG repeats. We characterized -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) currents and their modulation by cyclothiazide (CTZ) as well as N-methyl-D-aspartate (NMDA) currents and their Mg²⁺ sensitivity in acutely dissociated cortical pyramidal neurons in R6/2 transgenic and wild-type (WT) mice at 21 days (before overt symptoms), 40 days (when symptoms begin), and 80 days (fully symptomatic). AMPA currents, alone or in the presence of CTZ, were smaller in 21- and 40-day-old R6/2 groups compared with WT mice. In R6/2 mice, more neurons displayed desensitizing AMPA currents in the presence of CTZ, indicating increased expression of "flop" splice variants, whereas the majority of WT cells expressed the "flip" variants of AMPA receptor subunits. NMDA peak currents also were smaller in R6/2 pyramidal neurons at 21 days. At 40 days, NMDA currents were similar in WT and R6/2 mice but Mg²⁺ sensitivity was greater in R6/2 mice, resulting in smaller NMDA currents in the presence of Mg²⁺. Differences in AMPA and NMDA currents between WT and R6/2 cells were no longer detected at 80 days. Our findings indicate that currents induced by glutamate receptor agonists are decreased in isolated cortical pyramidal neurons from R6/2 mice and that this decrease occurs early. Altered glutamate receptor function could contribute to changes in cortical output and may underlie some of the cognitive and motor impairments in this animal model of HD.

This article has been cited by other articles:

				D. M. Cummings, V. M. Andre, B. O. Uzgil, S. M. Gee, Y. E. Fisher, C. Cepeda, and M. S. Levine Alterations in Cortical Excitation and Inhibition in Genetic Mouse Models of Huntington's Disease J. Neurosci., August 19, 2009; 29(33): 10371 - 10386. [Abstract] [Full Text] [PDF]

				P. R. Joshi, N.-P. Wu, V. M. Andre, D. M. Cummings, C. Cepeda, J. A. Joyce, J. B. Carroll, B. R. Leavitt, M. R. Hayden, M. S. Levine, et al. Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease J. Neurosci., February 25, 2009; 29(8): 2414 - 2427. [Abstract] [Full Text] [PDF]

				R. K. Graham, M. A. Pouladi, P. Joshi, G. Lu, Y. Deng, N.-P. Wu, B. E. Figueroa, M. Metzler, V. M. Andre, E. J. Slow, et al. Differential Susceptibility to Excitotoxic Stress in YAC128 Mouse Models of Huntington Disease between Initiation and Progression of Disease J. Neurosci., February 18, 2009; 29(7): 2193 - 2204. [Abstract] [Full Text] [PDF]

				A. J. Milnerwood and L. A. Raymond Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load J. Physiol., December 15, 2007; 585(3): 817 - 831. [Abstract] [Full Text] [PDF]

				M. M. Y. Fan, H. B. Fernandes, L. Y. J. Zhang, M. R. Hayden, and L. A. Raymond Altered NMDA Receptor Trafficking in a Yeast Artificial Chromosome Transgenic Mouse Model of Huntington's Disease J. Neurosci., April 4, 2007; 27(14): 3768 - 3779. [Abstract] [Full Text] [PDF]

				D. M. Cummings, A. J. Milnerwood, G. M. Dallerac, V. Waights, J. Y. Brown, S. C. Vatsavayai, M. C. Hirst, and K. P.S.J. Murphy Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of huntington's disease Hum. Mol. Genet., October 1, 2006; 15(19): 2856 - 2868. [Abstract] [Full Text] [PDF]